Award

Supply and support of HLA Rapid typing systems

NHS BLOOD & TRANSPLANT

This public procurement record has 1 release in its history.

Award

04 Mar 2021 at 22:56

Summary of the contracting process

The NHS Blood and Transplant (NHSBT) has recently completed a tender process titled "Supply and support of HLA Rapid typing systems" in the healthcare industry. This procurement was conducted under an open procedure, focusing on the procurement of goods and specifically biomedical equipment necessary for histocompatibility and immunogenetics. The tender initiated with key dates surrounding the contract award, including a signed agreement dated 12th February 2021 for a four-year Framework Agreement. The relevant delivery locations include a network of six laboratories across the UK, specifically in regions such as Birmingham, Bristol, Colindale, Newcastle, Sheffield, and Tooting.

This contracting process offers significant opportunities for small and medium-sized enterprises (SMEs) in the medical equipment and consumables sector, particularly those capable of providing rapid HLA typing systems and associated kits. Potential bidders should possess expertise in developing biomedical equipment and medical diagnostics to align with NHSBT's requirements for efficiency, timeliness, and cost-effectiveness. The awarded contracts cover both "New HLA (Rapid) Typing Equipment" and "Kits for HLA (rapid) typing systems," valued at £241,000 and £261,000 respectively, indicating a substantial market opportunity for suppliers in this niche area.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Supply and support of HLA Rapid typing systems

Notice Description

Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require HLA typing systems that can produce a result in less than two hours. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - New HLA (Rapid) typing equipment - awarded to VH Bio Lot 2 - Kits for HLA (Rapid) typing systems - awarded to VH Bio Ltd and Alpha Biotech Ltd

Lot Information

New HLA (Rapid) Typing Equipment

Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require HLA typing systems that can produce a result in less than two hours. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - New HLA (Rapid) typing equipment - awarded to VH Bio Lot 2 - Kits for HLA (Rapid) typing systems - awarded to VH Bio Ltd and Alpha Biotech Ltd

Kits for HLA (rapid) typing systems

Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require HLA typing systems that can produce a result in less than two hours. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - New HLA (Rapid) typing equipment - awarded to VH Bio Lot 2 - Kits for HLA (Rapid) typing systems - awarded to VH Bio Ltd and Alpha Biotech Ltd

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02988c
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/004407-2021
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

38 - Laboratory, optical and precision equipments (excl. glasses)

50 - Repair and maintenance services


CPV Codes

33100000 - Medical equipments

33140000 - Medical consumables

33141625 - Diagnostic kits

38434540 - Biomedical equipment

50421000 - Repair and maintenance services of medical equipment

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£502,000 £500K-£1M

Notice Dates

Publication Date
4 Mar 20214 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
12 Feb 20215 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS BLOOD & TRANSPLANT
Contact Name
Not specified
Contact Email
marta.drozdzowska@nhsbt.nhs.uk
Contact Phone
Not specified

Buyer Location

Locality
FILTON, BRISTOL
Postcode
BS34 7QH
Post Town
Bristol
Country
England

Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
Not specified

Local Authority
South Gloucestershire
Electoral Ward
Filton
Westminster Constituency
Filton and Bradley Stoke

Supplier Information

Number of Suppliers
2
Supplier Names

ALPHA BIOTECH

VH BIO

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02988c-2021-03-04T22:56:10Z",
    "date": "2021-03-04T22:56:10Z",
    "ocid": "ocds-h6vhtk-02988c",
    "initiationType": "tender",
    "tender": {
        "id": "NHSBT1250",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Supply and support of HLA Rapid typing systems",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "38434540",
            "description": "Biomedical equipment"
        },
        "mainProcurementCategory": "goods",
        "description": "Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require HLA typing systems that can produce a result in less than two hours. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - New HLA (Rapid) typing equipment - awarded to VH Bio Lot 2 - Kits for HLA (Rapid) typing systems - awarded to VH Bio Ltd and Alpha Biotech Ltd",
        "lots": [
            {
                "id": "1",
                "title": "New HLA (Rapid) Typing Equipment",
                "description": "Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require HLA typing systems that can produce a result in less than two hours. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - New HLA (Rapid) typing equipment - awarded to VH Bio Lot 2 - Kits for HLA (Rapid) typing systems - awarded to VH Bio Ltd and Alpha Biotech Ltd",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            },
            {
                "id": "2",
                "title": "Kits for HLA (rapid) typing systems",
                "description": "Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require HLA typing systems that can produce a result in less than two hours. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - New HLA (Rapid) typing equipment - awarded to VH Bio Lot 2 - Kits for HLA (Rapid) typing systems - awarded to VH Bio Ltd and Alpha Biotech Ltd",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33100000",
                        "description": "Medical equipments"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33140000",
                        "description": "Medical consumables"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33141625",
                        "description": "Diagnostic kits"
                    },
                    {
                        "scheme": "CPV",
                        "id": "38434540",
                        "description": "Biomedical equipment"
                    },
                    {
                        "scheme": "CPV",
                        "id": "50421000",
                        "description": "Repair and maintenance services of medical equipment"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            },
            {
                "id": "2",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33140000",
                        "description": "Medical consumables"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "2"
            }
        ],
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "techniques": {
            "hasFrameworkAgreement": true
        },
        "coveredBy": [
            "GPA"
        ]
    },
    "awards": [
        {
            "id": "004407-2021-NHSBT1250-1",
            "relatedLots": [
                "1"
            ],
            "title": "New HLA (Rapid) Typing Equipment",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-7666",
                    "name": "VH Bio Ltd."
                }
            ]
        },
        {
            "id": "004407-2021-NHSBT1250-2",
            "relatedLots": [
                "2"
            ],
            "title": "Kits for HLA (rapid) typing systems",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-7667",
                    "name": "VH Bio"
                },
                {
                    "id": "GB-FTS-7668",
                    "name": "Alpha Biotech Ltd"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-1395",
            "name": "NHS Blood & Transplant",
            "identifier": {
                "legalName": "NHS Blood & Transplant"
            },
            "address": {
                "streetAddress": "North Bristol Park",
                "locality": "Filton, Bristol",
                "region": "UK",
                "postalCode": "BS34 7QH",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "marta.drozdzowska@nhsbt.nhs.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "http://www.nhsbt.nhs.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-7666",
            "name": "VH Bio Ltd.",
            "identifier": {
                "legalName": "VH Bio Ltd."
            },
            "address": {
                "locality": "Gateshead",
                "region": "UK",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme"
            }
        },
        {
            "id": "GB-FTS-7667",
            "name": "VH Bio",
            "identifier": {
                "legalName": "VH Bio"
            },
            "address": {
                "locality": "Gateshead",
                "region": "UK",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme"
            }
        },
        {
            "id": "GB-FTS-7668",
            "name": "Alpha Biotech Ltd",
            "identifier": {
                "legalName": "Alpha Biotech Ltd"
            },
            "address": {
                "locality": "Killearn",
                "region": "UK",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme"
            }
        },
        {
            "id": "GB-FTS-3034",
            "name": "NHS Blood and Transplant",
            "identifier": {
                "legalName": "NHS Blood and Transplant"
            },
            "address": {
                "locality": "Bristol",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-1395",
        "name": "NHS Blood & Transplant"
    },
    "contracts": [
        {
            "id": "004407-2021-NHSBT1250-1",
            "awardID": "004407-2021-NHSBT1250-1",
            "title": "New HLA (Rapid) Typing Equipment",
            "status": "active",
            "value": {
                "amount": 241000,
                "currency": "GBP"
            },
            "dateSigned": "2021-02-12T00:00:00Z"
        },
        {
            "id": "004407-2021-NHSBT1250-2",
            "awardID": "004407-2021-NHSBT1250-2",
            "title": "Kits for HLA (rapid) typing systems",
            "status": "active",
            "value": {
                "amount": 261000,
                "currency": "GBP"
            },
            "dateSigned": "2021-02-12T00:00:00Z"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 3
            },
            {
                "id": "2",
                "measure": "bids",
                "relatedLot": "2",
                "value": 4
            }
        ]
    },
    "links": [
        {
            "rel": "prev",
            "href": "https://ted.europa.eu/udl?uri=TED:NOTICE:565877-2019:TEXT:EN:HTML"
        }
    ],
    "language": "en"
}